{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:47:41Z","timestamp":1791895661622,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD098428"],"award-info":[{"award-number":["R01HD098428"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Division of Intramural Research, National Human Genome Research Institute"},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Division of Intramural Research, National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1136\/ard-2023-225085","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T13:25:18Z","timestamp":1708953918000},"page":"787-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Interrupting an IFN-\u03b3-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne"],"prefix":"10.1016","volume":"83","author":[{"given":"Wonyong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxia Li","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gadina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyi-Chia Richard","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Randazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Pimpale Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Manthiram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Canna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K","family":"Ombrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Aksentijevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Jin","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-225085_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","article-title":"A new Autosomal dominant disorder of Pyogenic sterile arthritis, Pyoderma Gangrenosum, and Acne: PAPA syndrome","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1136\/ard-2023-225085_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.56.4.570","article-title":"\u201c\u201cStreaking Leukocyte factor\u201d arthritis, and Pyoderma Gangrenosum\u201d","volume":"56","author":"Jacobs","year":"1975","journal-title":"Pediatrics"},{"key":"10.1136\/ard-2023-225085_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","article-title":"Mutations in Cd2Bp1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an Autoinflammatory disorder","volume":"11","author":"Wise","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1136\/ard-2023-225085_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/138920210793175921","article-title":"Clinical, molecular, and genetic characteristics of PAPA syndrome: A review","volume":"11","author":"Smith","year":"2010","journal-title":"Curr Genomics"},{"key":"10.1136\/ard-2023-225085_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-015-0144-2","article-title":"F-BAR family proteins, emerging regulators for cell membrane dynamic changes-from structure to human diseases","volume":"8","author":"Liu","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1136\/ard-2023-225085_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00018-022-04173-w","article-title":"Pstpip1-LYP phosphatase interaction: structural basis and implications for Autoinflammatory disorders","volume":"79","author":"Manso","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1136\/ard-2023-225085_bib7","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1111\/febs.12912","article-title":"Proline-Serine-Threonine phosphatase interacting protein 1 inhibition of T-cell receptor signaling depends on its Sh3 domain","volume":"281","author":"Marcos","year":"2014","journal-title":"FEBS J"},{"key":"10.1136\/ard-2023-225085_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1083\/jcb.138.4.845","article-title":"PSTPIP: a tyrosine Phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase","volume":"138","author":"Spencer","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1136\/ard-2023-225085_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164829","article-title":"BAR proteins Pstpip1\/2 regulate Podosome Dynamics and the Resorption activity of Osteoclasts","volume":"11","author":"Sztacho","year":"2016","journal-title":"PLoS One"},{"key":"10.1136\/ard-2023-225085_bib10","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2013-07-516948","article-title":"The F-BAR protein Pstpip1 controls extracellular matrix degradation and Filopodia formation in Macrophages","volume":"123","author":"Starnes","year":"2014","journal-title":"Blood"},{"key":"10.1136\/ard-2023-225085_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(02)00516-2","article-title":"The Wiskott-Aldrich syndrome protein acts downstream of Cd2 and the Cd2Ap and Pstpip1 Adaptors to promote formation of the immunological Synapse","volume":"18","author":"Badour","year":"2003","journal-title":"Immunity"},{"key":"10.1136\/ard-2023-225085_bib12","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.2135380100","article-title":"Pyrin binds the Pstpip1\/Cd2Bp1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway","volume":"100","author":"Shoham","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2023-225085_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01745","article-title":"The Pyrin Inflammasome in health and disease","volume":"10","author":"Schnappauf","year":"2019","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2023-225085_bib14","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V95.10.3223","article-title":"The gene for familial Mediterranean fever, MEFV, is expressed in early Leukocyte development and is regulated in response to inflammatory mediators","volume":"95","author":"Centola","year":"2000","journal-title":"Blood"},{"key":"10.1136\/ard-2023-225085_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13449","article-title":"Innate immune sensing of bacterial modifications of Rho Gtpases by the Pyrin Inflammasome","volume":"513","author":"Xu","year":"2014","journal-title":"Nature"},{"key":"10.1136\/ard-2023-225085_bib16","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin Inflammasome activation and Rhoa signaling in the Autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1136\/ard-2023-225085_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","article-title":"The International FMF consortium. ancient Missense mutations in a new member of the Roret gene family are likely to cause familial Mediterranean fever","volume":"90","year":"1997","journal-title":"Cell"},{"key":"10.1136\/ard-2023-225085_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever","volume":"17","year":"1997","journal-title":"Nat Genet"},{"key":"10.1136\/ard-2023-225085_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1471","article-title":"Familial Autoinflammation with Neutrophilic Dermatosis reveals a regulatory mechanism of Pyrin activation","volume":"8","author":"Masters","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1136\/ard-2023-225085_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20161228","article-title":"Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by Mutation in actin-regulatory gene Wdr1","volume":"214","author":"Standing","year":"2017","journal-title":"J Exp Med"},{"key":"10.1136\/ard-2023-225085_bib21","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1084\/jem.20190147","article-title":"A novel disorder involving Dyshematopoiesis, inflammation, and HLH due to aberrant Cdc42 function","volume":"216","author":"Lam","year":"2019","journal-title":"J Exp Med"},{"key":"10.1136\/ard-2023-225085_bib22","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jaci.2019.06.017","article-title":"Severe Autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 Homolog (Cdc42) successfully treated with IL-1Beta inhibition","volume":"144","author":"Gernez","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1136\/ard-2023-225085_bib23","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211889","article-title":"Trapping of Cdc42 C-terminal variants in the Golgi drives Pyrin Inflammasome Hyperactivation","volume":"219","author":"Nishitani-Isa","year":"2022","journal-title":"J Exp Med"},{"key":"10.1136\/ard-2023-225085_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2007.08.029","article-title":"Pyrin activates the ASC Pyroptosome in response to engagement by Autoinflammatory Pstpip1 Mutants","volume":"28","author":"Yu","year":"2007","journal-title":"Mol Cell"},{"key":"10.1136\/ard-2023-225085_bib25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/keh479","article-title":"Anakinra for flares of Pyogenic arthritis in PAPA syndrome","volume":"44","author":"Dierselhuis","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225085_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","article-title":"Targeted treatment of Pyoderma Gangrenosum in PAPA (Pyogenic arthritis, Pyoderma Gangrenosum and Acne) syndrome with the recombinant human Interleukin-1 receptor antagonist Anakinra","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1136\/ard-2023-225085_bib27","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/rheumatology\/kew031","article-title":"Disease activity accounts for long-term efficacy of IL-1 blockers in Pyogenic sterile arthritis Pyoderma Gangrenosum and severe Acne syndrome","volume":"55","author":"Omenetti","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225085_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/art.41976","article-title":"Excess serum Interleukin-18 distinguishes patients with pathogenic mutations in Pstpip1","volume":"74","author":"Stone","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-225085_bib29","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1074\/jbc.M112.443077","article-title":"Inflammation in mice Ectopically expressing human Pyogenic arthritis, Pyoderma Gangrenosum, and Acne (PAPA) syndrome-associated Pstpip1 A230t mutant proteins","volume":"288","author":"Wang","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1136\/ard-2023-225085_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1136\/ard-2023-225085_bib31","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1136\/annrheumdis-2018-213746","article-title":"Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome","volume":"77","author":"Mistry","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225085_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-024-0921-5_1","article-title":"Regulation of IFN-gamma expression","volume":"941","author":"Fenimore","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1136\/ard-2023-225085_bib33","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.4049\/jimmunol.170.11.5464","article-title":"IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells","volume":"170","author":"Strengell","year":"2003","journal-title":"J Immunol"},{"key":"10.1136\/ard-2023-225085_bib34","doi-asserted-by":"crossref","first-page":"E4857","DOI":"10.1073\/pnas.1601700113","article-title":"Site-specific Phosphorylation and Microtubule Dynamics control Pyrin Inflammasome activation","volume":"113","author":"Gao","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2023-225085_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/humu.9229","article-title":"\u201cThe West side story: MEFV haplotype in Spanish FMF patients and controls, and evidence of high LD and a Recombination \u201chot-spot\u201d at the MEFV locus\u201d","volume":"23","author":"Aldea","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1136\/ard-2023-225085_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/annrheumdis-2012-202580","article-title":"MEFV mutations affecting Pyrin amino acid 577 cause Autosomal dominant Autoinflammatory disease","volume":"73","author":"Stoffels","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225085_bib37","author":"Nakaseko"},{"key":"10.1136\/ard-2023-225085_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41419-023-05745-9","article-title":"Mutations in the B30.2 and the central Helical scaffold domains of Pyrin Differentially affect Inflammasome activation","volume":"14","author":"Chirita","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1136\/ard-2023-225085_bib39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","article-title":"Levels of Interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset still\u2019s disease","volume":"44","author":"Kawashima","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225085_bib40","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/art.10389","article-title":"Highly elevated serum levels of Interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al","volume":"46","author":"Maeno","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225085_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10061164","article-title":"The pathogenic role of Interferons in the Hyperinflammatory response on adult-onset still\u2019s disease and macrophage activation syndrome: paving the way towards new therapeutic targets","volume":"10","author":"Di Cola","year":"2021","journal-title":"J Clin Med"},{"key":"10.1136\/ard-2023-225085_bib42","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/annrheumdis-2019-216699","article-title":"Tofacitinib in refractory adult-onset still\u2019s disease: 14 cases from a single centre in China","volume":"79","author":"Hu","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225085_bib43","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keac440","article-title":"JAK inhibitors in difficult-to-treat adult-onset still\u2019s disease and systemic-onset juvenile idiopathic arthritis","volume":"62","author":"Gillard","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225085_bib44","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard-2022-223739","article-title":"Efficacy and safety of Emapalumab in macrophage activation syndrome","volume":"82","author":"De Benedetti","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724001341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724001341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-225085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T03:18:56Z","timestamp":1739503136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724001341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0003496724001341"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-225085","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interrupting an IFN-\u03b3-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-225085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}